顯示第 961 至 976 項結果，共 6874 項
-
Anti-CD33 [hP67.6 (Gemtuzumab)] (Ab00283-23.0-BT)
-
Anti-CD33 [hP67.6 (Gemtuzumab)] (Ab00283-23.0)
-
Anti-CD3e [Visilizumab (HuM291)] (Ab02390-10.0-BT)
-
Anti-CD3e [Visilizumab (HuM291)] (Ab02390-10.0)
-
Anti-CD3e [Visilizumab (HuM291)] (Ab02390-10.3-BT)
-
Anti-CD3e [Visilizumab (HuM291)] (Ab02390-10.3)
-
Anti-CD3e [Visilizumab (HuM291)] (Ab02390-23.0-BT)
-
Anti-CD3e [Visilizumab (HuM291)] (Ab02390-23.0)
-
Anti-CD3e [Visilizumab (HuM291)] (Ab02390-3.0-BT)
-
Anti-CD3e [Visilizumab (HuM291)] (Ab02390-3.0)
-
Anti-CD3e [Visilizumab (HuM291)] (Ab02390-3.3-BT)
-
Anti-CD3e [Visilizumab (HuM291)] (Ab02390-3.3)
-
Anti-CD4 [CE9.1 (Clenoliximab)] (Ab00450-1.1-BT)
-
Anti-CD4 [CE9.1 (Clenoliximab)] (Ab00450-1.1)
-
Anti-CD4 [CE9.1 (Clenoliximab)] (Ab00450-1.4-BT)
-
Anti-CD4 [CE9.1 (Clenoliximab)] (Ab00450-1.4)